May 2016—With a grant from Innovate UK, Affymetrix will develop a health and economic benefits assessment for replacing surveillance cystoscopies with noninvasive genomic profiling from urinary cell-free DNA using the OncoScan FFPE Assay Kit.
Read More »Affymetrix, Luminex distribution agreement, 11/15
November 2015—Affymetrix and Luminex announced a distribution agreement under which eBioscience, a business unit of Affymetrix, will sell Luminex’s Magpix, Luminex 200, and Flexmap 3D multiplexed assay platforms in specified countries in the Americas, Asia, and Europe.
Read More »Affymetrix, Ariosa Diagnostics sign supply agreement, 12/14
December 2014—Affymetrix and Ariosa Diagnostics announced the signing of a multiyear supply agreement covering Affymetrix arrays and instruments to be used as part of Ariosa’s Harmony Non-Invasive Prenatal Test. The partnership enables Ariosa to pursue the development of a Harmony test kit that will allow laboratories worldwide to adopt and perform this test.
Read More »FDA clears CytoScan Dx, 3/14
March 2014—Affymetrix received FDA 510(k) clearance to market its CytoScan Dx assay, intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing. CytoÂScan Dx is designed to help diagnose children’s developmental and intellectual disabilities more comprehensively by enabling a high-resolution, genome-wide analysis of genetic aberrations.
Read More »Customized system for cytogenetics assay, 4/13:88
Hamilton Robotics announced that the CytoScan automated target preparation solution from Affymetrix is built on Hamilton’s customizable Microlab Nimbus 96 workstation. The Nimbus 96 instrument automates target preparation for the CytoScan cytogenetics solution, which offers broad coverage for detecting human chromosomal aberrations.
Read More »